Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Aug 26, 2023 (3 years ago)

Dr. Berne's MSM MIST 15% Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Dr. Berne's MSM MIST 15% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr. Berne's Whole Health Products, Tesuque, NM, 87574, [email protected].

Recalling firm
Dr. Berne's Whole Health Products
Origin
NM, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0034-2024 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Dr. Berne's Whole Health Products

All 2023 recalls

Other cgmp deviation recalls from 2023

All cgmp deviation recalls
Class II · Moderate risk

Sertraline Tablets

CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

Ongoing cGMP deviation Legacy Pharmaceutical Packaging LLC NDC 68645-523-54 D-0205-2024
Class II · Moderate risk

Oxygen

cGMP Deviations

Terminated cGMP deviation Family Medical Supply Inc D-0106-2024
Class III · Low risk

V-FORCE Homeopathic

Incorrect Product Formulation: product contains Active Ingredient Glandula Suprarenalis Suis 8X instead of Glandula Suprarenalis Bovine 8X (as stated on the product label).

Terminated cGMP deviation Grato Holdings, Inc. D-0099-2024
Class II · Moderate risk

Strong Iodine Solution U.S.P.

CGMP Deviations: Recall due to the absence of USP CGMP compendial requirements.

Terminated cGMP deviation Safecor Health, LLC NDC 48433-230-15 D-0082-2024